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Radionuclide Bone Imaging
in the Evaluation
of Prostatic Cancer
Daniel S. Marks, M D and William R. Eyler, M D *

F o r any patient harboring a mal ignant neoplasm, methods of determining the extent of
disease are of great value in planning the
best course of action. Amongthe procedures
available today, radionuclide bone imaging
is the most sensitive means of detecting
skeletal extension of tumors. This report
presents our experience with bone imaging
in patients with cancer of the prostate.

Radionuclide bone imaging is a rapid,
easily performed, noninvasive method for
evaluation of skeletal disease in carcinoma
of the prostate, or any other malignancy. In a
significant number of cases, it may provide
the only evidence of metastases and frequently demonstrates more widespread Involvement than previously suspected. Thus,
it may redirect the chosen course of therapy
or localize sources of bone pain that are not
radiographically
apparent. Sixty-two percent of 42 patients studied were abnormal,
of which 12% had no radiographic evidence
of disease.

Radionuclide bone imaging is dependent
on bone production as a physiologic response to an injury or destructive process.
Areas are sought of increased osteoblastic
activity detected by display of increased
radionuclide deposition. Even those lesions
shown to be purely lytic on radiographs have
been found microscopically to have a reactive front resulting in mixed destructive and
productive areas.
Unfortunately, no isotope of calcium is
useful in clinical nuclear medicine, but isotopes of strontium and fluorine have been
used in the recent past with accumulation of
m u c h useful data. These agents, w h i l e
clinically more suitable than calcium, are
also less than ideal because of their high
gamma energies, inappropriate half-lives
and cost. With the introduction of phosphate
compounds labeled with '^'^Tc, bone imaging became possible as a screening examination in patients with malignancy.' The
energy of ^'""Tc (140 KeV) is more efficiently
detected by the sodium iodide crystals used
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Figure la
Patient is a 79-year-old man with cancer of the prostate discovered six year previously, who now
complains of back pain. Images show involvement of the pelvis, which was previously known, as well as
uptake in the spine, left scapula, and several ribs. The patient's right side is to the reader's right (marked by
a small cross on three of the views).
in modern scanners and gamma cameras,
allowing for a marked increase in resolution
and information density. Indeed, pedicles of
the vertebrae are routinely shown on bone
images made with a well adjusted gamma
camera. Several studies"-'-' have clearly
documented superior and improved lesion
detection by Tc-phosphate c o m p o u n d s
compared to ''Sr and ^*F. No reactions to the
injection of Tc-phosphate compounds have
been reported," and the radiation dose of
0.1-0.45 rads' allows for multiple studies,
use in c h i l d r e n and in non-neoplastic
conditions.

studied by bone imaging were reviewed.
Most were newly discovered cases, although
a few had been identified several months
prior to bone imaging. One case (Figure 1)
had been known for six years, but was
initially evaluated by radionuclide study
during this time; the case is included for
illustrative purposes.
All patients received 15 mCi of ^''"Tc
pyrophosphate prepared from commercially
available kits. Gamma camera images were
obtained three to four hours after intravenous injection of the radioagent. Comparison with radiographs was made at the
time of interpretation. In most cases, the
radiographs and radionuclide images were
obtained within a few days of each other; in
no case was the time interval between studies inappropriate. In one case of metastatic

Methods
From January, 1974, through September,
1975, at Henry Ford Hospital, 42 patients
with cancer of the prostate who had been
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Figure l b
Radiographs show osteoblastic involvement of the pelvis, but the mild degenerative change in the spine is
not sufficient explanation for the abnormalities seen on the images; therefore, metastatic disease Is more
extensive than demonstrated radiographically.
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disease, no radiographs were available for
comparison.

cal radiotherapeutic or surgical treatment.
Additionally, it is now well known that 30%
to 50% of bone mass must be removed
before an abnormality can be seen on radiographs.^-' This amount of bone loss is equivalent to a lesion 1.0-1.5 cm in diameter.' In
the axial skeleton, even larger lesions may
be difficult to identify radiographically, especially since the age group concerned with
prostatic malignancy frequently has co-existent degenerative disease. Detection of even
very small lesions is made possible by the
concentration of activity within them.' Also
of note is the absence of any false negative
results in ourseries. Other publications have
reported low false negative results of
0-5%!-'-"'-" using «5Sr and ''R The figures
should become even lower with the Tcphosphate compounds. Abnormalities on
scan frequently precede radiographic findings by several months and one author
claims an interval of up to three years.^

Results are tabulated in Table I. A normal
examination is defined as one with no areas
of increased activity other than physiologic
activity seen in large joints, the sacroiliac
areas, the tips of the scapulae and the base of
the skull. Abnormal studies not considered
indicative of metastatic disease are those in
which areas of increased activity can be
explained by degenerative changes or other
benign conditions seen on the radiographs
(Table II). This list is far from complete as
many non-neoplastic conditions can result
in increased activity. Abnormal images suspicious for metastatic disease are those with
one or two active areas for which no explanation can be seen on the radiographs. The
typical pattern of metastatic abnormality
(Figure 2) is that of numerous widespread
areas of increased activity with or without
radiographic changes compatible with metastatic disease. Usually, metastases display
intense activity as opposed to degenerative
disease which shows mildly increased activity in most cases. Any factor increasing
bone mass or density can cause a " h o t " area.

Discussion
Our results again emphasize the validity
and value of bone imaging in cancer of
the prostate. Several previous studIggs,',11,12-13 have reported positive radionuclide images in 47% to 70% of patients
examined for prostatic neoplasm. This correlates well with the 62% incidence of positive studies in this report. Additionally, it has
now been shown that 19% to 30% of these
patients will have abnormal images in the
presence of normal radiographs. 1 , 9 , 1 1 , 1 4

Sixteen patients (38%) had either normal
studies or findings other than metastases.
Twenty-six (62%) had positive studies of
which eleven (26%) had suspicious findings,
thirteen (31%) showed atypically metastatic
pattern, and two patients (5%) had an initial ly normal study which became abnormal
on a progress examination. This change, of
course, is highly suspicious of metastatic
disease.

The patient who shows typical metastatic
patterns, whether anticipated or not, does
not present any significant dilemma as to
further management; palliative therapy is
indicated. Likewise, the patient with a normal study should present little p r o b l e m
(provided other studies are within normal
limits); radical, curative therapy is to be
considered.

The thirteen cases with a typical metastatic pattern on the radionuclide study are
further analyzed in Table III. The most significant finding is that five patients (38%)
had no metastases by radiography. Thus, the
radionuclide bone image was the only evidence of the widespread nature of their
disease. This represents 12% of the total
number of patients included in this study.
Such results would obviously preclude radi-

What, then, is to be done with the suspicious group? If some other condition precludes curative surgery or radiotherapy,
progress bone images should be obtained at
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Table I
BONE IMAGES IN EARLY CANCER OF THE PROSTATE (TOTAL 12 STUDIES)
ABNORMA L

ABNORMAL

NOT CONSIDERED

SUSPICIOUS OF

METASTATIC

METASTATIC DISEASE
(ONE OR TWO ABNORMAL

ABNORMAL

NITIALLY NORMAL

PATTERN CONS I STENT BECOMING ABNORMAL
WITH METASTATIC
DISEASE

AREAS NOT EXPLAINED

ON PROGRESS STUDY
(SUSPICIOUS OF
METASTATIC DISEASE

ON RADIOGRAPHS)
I I (26{)

TOTAL

16 ( 3 8 ? )

13 ( 3 1 J )

TOTAL 26

(62tl

Table II
CAUSES OF ABNORMALIT ES NOT CONS 1DERED AS METASTAT1C

NON BONY UPTAKE

1

ANKYLOS1NG

1

SPONDYL1T S

TRAUMA

1

DEGENERATIVE

DISEASE

4

Table III
ABNORMAL STUDIES

RAD lOGRAPHS
NORMA L

NO COMPARISON
RADIOGRAPHS

5

1

(8?)

(30?)

(12$

of a 1 1

CONSISTENT

WITH METASTASES ( 1 3 )

SAME LESIONS
SEEN ON BOTH
RADlOGRAPH
AND IMAGES

2
( 16?)

DISEASE MORE
EXTENSIVE ON
IMAGES THAN ON
RADIOGRAPHS

ABNORMAL
RADIOGRAPHS,
NORMAL
1 MAGES

5
(38?)

stud!es)

NOTE:

OF THE TWO STUDIES WHICH BECAME AB NORMAL AFTER AN I N I T 1 ALLY
NORMAL IMAGE, ONE HAD NO CORRESPON DING RADIOGRAPHIC CH ANGE
AND ONE HAD MORE EXTENSIVE DISEASE ON THE IMAGES THAN SEEN
ON RADIOGRAPHS.
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Figure 2a — See legend opposite page
appropriate intervals. If the presence or absence of bone metastases means the difference between c u r a t i v e and p a l l i a t i v e
treatment, something more immediate must
be done. In some cases, laminography will
reveal the lesion,i^ and confirm the diagnosis. In accessible areas, bone biopsy
should be considered. If tumor is found, the
diagnosis is secure. One should be cautious
of negative results, however, as small lesions
can be missed at the time of biopsy. Should
there beany doubt, a repeat bone image may
reveal whether or not the appropriate area

has been sampled. It is also possible to
localize the area by radionuclide imaging
and mark the overlying skin surface.
Solitary areas of abnormality should also
be considered as possible metastases. One
recent report^' states that 54% of 100 single
lesions reviewed were found to be metastatic disease. The report covered various
tumors, four of which were prostate. In this
same report, the authors found that a sol itary
lesion accounted for 11% of their abnormal
images. The find ing of a single metastasis is a
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Figures 2a and 2b
This patient is a 50-year-old man with cancer of the prostate whose images (a) opposite page show diffuse
areasof increased activity, while radiographs (b) fail to reveal any specific abnormality (selected areas;
other views were also unremarkable). This combination of appearances is characteristic of metastatic
disease.
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c o n t r a - i n d i c a t i o n to c u r a t i v e t r e a t m e n t ,

uptake of the radionuclide may be a clue to

even if within the radiotherapy field used in

this phenomenon.i'' These patients w i l l have

prostatic cancer. Other lesions w i l l become

radiographic evidence of their disease. False

apparent w i t h time in most cases.

positive results (due to benign conditions)
should be virtually eliminated by reviewing

As previously mentioned, false negative

the imageswith current radiographs in hand.

studies are uncommon and there were none

Some benign conditions reveal themselves

in our series. Moreover, some causes of false

by a typical

negative results in patients w i t h uniform,

distribution. Rarely, bone metastases may

radionuclide appearance or

diffuse disease (and thus diffuse, but rela-

present as a negative or " c o l d " area^" but we

tively equal increased activity) have recently

are not aware of any such findings in car-

come to light.1'' Diminished or absent renal

cinoma of the prostate.
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